FOGHORN THERAPEUTICS INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+223.8% +$6M
$9M
R&D↑+7.5% +$2M
$22M
D&A↑+5.4% +$41K
$802K
Operating Income↑+22.4% +$5M
$-19M
EBITDA↑+5.4% +$41K
$802K
Interest Expense
—
Other Income/Expense
$5M
Pretax Income
$-19M
Tax Provision
$0
Net Income↑+17.1% +$3M
$-16M
Operating Margin↑+78.6pts
-226.9%
Net Margin↑+50.5pts
-194.4%
Effective Tax Rate
0.0%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-4.8pts
0.0%
Operating Lease Cost↓-40.6% -$788K
$1M
Revenue YoY Variation↑+274.3pts
223.8%
Income YoY Variation↑+62.1pts
22.4%
Revenue QoQ Variation↑+76.8pts
13.4%
Income QoQ Variation↑+1.9pts
12.3%